Literature DB >> 10329964

VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway.

W G Mayhan1.   

Abstract

It appears that the expression of vascular endothelial growth factor (VEGF) is increased during brain injury and thus may contribute to disruption of the blood-brain barrier (BBB) during cerebrovascular trauma. The first goal of this study was to determine the effect of VEGF on permeability of the BBB in vivo. The second goal was to determine possible cellular mechanisms by which VEGF increases permeability of the BBB. We examined the pial microcirculation in rats using intravital fluorescence microscopy. Permeability of the BBB [clearance of FITC-labeled dextran of molecular mass 10,000 Da (FITC-dextran-10K)] and diameter of pial arterioles were measured in absence and presence of VEGF (0.01 and 0.1 nM). During superfusion with vehicle (saline), clearance of FITC-dextran-10K from pial vessels was minimal and diameter of pial arterioles remained constant. Topical application of VEGF (0.01 nM) did not alter permeability of the BBB to FITC-dextran-10K or arteriolar diameter. However, superfusion with VEGF (0.1 nM) produced a marked increase in clearance of FITC-dextran-10K and a modest dilatation of pial arterioles. To determine a potential role for nitric oxide and stimulation of soluble guanylate cyclase in VEGF-induced increases in permeability of the BBB and arteriolar dilatation, we examined the effects of NG-monomethyl-L-arginine (L-NMMA; 10 microM) and 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; 1.0 microM), respectively. L-NMMA and ODQ inhibited VEGF-induced increases in permeability of the BBB and arteriolar dilatation. The findings of the present study suggest that VEGF, which appears to be increased in brain tissue during cerebrovascular trauma, increases the permeability of the BBB via the synthesis/release of nitric oxide and subsequent activation of soluble guanylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329964     DOI: 10.1152/ajpcell.1999.276.5.C1148

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  44 in total

Review 1.  Factors controlling permeability of the blood-brain barrier.

Authors:  Mohammed M A Almutairi; Chen Gong; Yuexian G Xu; Yanzhong Chang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

Review 2.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

Review 3.  Targeted gene therapy for the treatment of heart failure.

Authors:  Kleopatra Rapti; Antoine H Chaanine; Roger J Hajjar
Journal:  Can J Cardiol       Date:  2011 May-Jun       Impact factor: 5.223

Review 4.  Role of the Golgi Apparatus in the Blood-Brain Barrier: Golgi Protection May Be a Targeted Therapy for Neurological Diseases.

Authors:  Shuwen Deng; Hui Liu; Ke Qiu; Hong You; Qiang Lei; Wei Lu
Journal:  Mol Neurobiol       Date:  2017-07-20       Impact factor: 5.590

Review 5.  Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.

Authors:  S Engelhardt; S Patkar; O O Ogunshola
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

6.  The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy.

Authors:  Malou P H Schreurs; Emily M Houston; Victor May; Marilyn J Cipolla
Journal:  FASEB J       Date:  2011-09-12       Impact factor: 5.191

Review 7.  The adaptation of the cerebral circulation to pregnancy: mechanisms and consequences.

Authors:  Marilyn J Cipolla
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-16       Impact factor: 6.200

8.  eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.

Authors:  Annarita Di Lorenzo; Michelle I Lin; Takahisa Murata; Shira Landskroner-Eiger; Michael Schleicher; Milankumar Kothiya; Yasuko Iwakiri; Jun Yu; Paul L Huang; William C Sessa
Journal:  J Cell Sci       Date:  2013-09-17       Impact factor: 5.285

9.  Febrigenic signaling to the brain does not involve nitric oxide.

Authors:  Alexandre A Steiner; Alla Y Rudaya; Andrei I Ivanov; Andrej A Romanovsky
Journal:  Br J Pharmacol       Date:  2004-03-08       Impact factor: 8.739

10.  HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model.

Authors:  Wanqiu Chen; Vikram Jadhav; Jiping Tang; John H Zhang
Journal:  Neurobiol Dis       Date:  2008-06-14       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.